GLP-1 series
Module 2 · Full field guide
GLP-1 Receptor Agonist Therapy: The Complete Briefing
Eleven themes from initiation through emerging evidence — titration ladders, tolerability, switching, lean mass, cardiovascular benefit, regain, virtual care, coverage, and communication.
23 slides · 25 minutes
Video coming soon
25-minute recorded module
What this module covers
- 01The GLP-1 treatment lifecycle
- 02Titration ladders: slow and steady
- 03Managing adverse effects and the tolerability playbook
- 04Hold, discontinue, restart or switch
- 05Preserving lean mass: a muscle-sparing protocol
- 06Beyond weight: protecting the heart (SELECT in numbers)
- 07Weight regain after discontinuation
- 08Virtual care at scale, with guardrails
- 09Coverage, prior authorization and medical necessity
- 10Communication, myths, and emerging evidence
Key takeaways
Titrate slowly; most dropout happens in month one.
Plan the exit before the first injection.
Coverage decisions turn on documentation quality.
Continue the series
Module 1
GLP-1–Based Therapies in Cardio-Oncology
Module 3
Obesity, Cardiometabolic Health & GLP-1 Therapies
Module 4
Managing Adverse Effects & Safety Considerations
Educational information only. It does not replace advice from your oncology or primary care team, and no treatment decision should be made from this module alone.